21 Ebooks door Rebecca A. English
Board on Health Sciences Policy & Institute of Medicine: Transforming Clinical Research in the United States
An ideal health care system relies on efficiently generating timely, accurate evidence to deliver on its promise of diminishing the divide between clinical practice and research. There are growing in …
PDF
Engels
DRM
€35.96
Board on Health Sciences Policy & Institute of Medicine: Building a National Framework for the Establishment of Regulatory Science for Drug Development
The Food and Drug Administration (FDA) is tasked with ensuring the safety and effectiveness of medicine. FDA’s science base must be strong enough to make certain that regulatory decisions are based o …
PDF
Engels
DRM
€21.19
Board on Health Sciences Policy & Institute of Medicine: Transforming Clinical Research in the United States
An ideal health care system relies on efficiently generating timely, accurate evidence to deliver on its promise of diminishing the divide between clinical practice and research. There are growing in …
EPUB
Engels
DRM
€51.34
Board on Health Sciences Policy & Institute of Medicine: Building a National Framework for the Establishment of Regulatory Science for Drug Development
The Food and Drug Administration (FDA) is tasked with ensuring the safety and effectiveness of medicine. FDA’s science base must be strong enough to make certain that regulatory decisions are based o …
EPUB
Engels
DRM
€30.87
Board on Health Sciences Policy & Institute of Medicine: Public Engagement and Clinical Trials
Clinical trials provide essential information needed to turn basic medical research findings into patient treatments. New treatments must be studied in large numbers of humans to find out whether the …
PDF
Engels
DRM
€3.84
Board on Health Sciences Policy & Institute of Medicine: Public Engagement and Clinical Trials
Clinical trials provide essential information needed to turn basic medical research findings into patient treatments. New treatments must be studied in large numbers of humans to find out whether the …
EPUB
Engels
DRM
€42.46
Board on Health Sciences Policy & Institute of Medicine: Facing the Reality of Drug-Resistant Tuberculosis in India
An estimated 8.8 million people fell ill with tuberculosis (TB) in 2010 and 1.4 million died from the disease. Although antibiotics to treat TB were developed in the 1950s and are effective against a …
PDF
Engels
DRM
€3.79
Board on Health Sciences Policy & Institute of Medicine: Facing the Reality of Drug-Resistant Tuberculosis in India
An estimated 8.8 million people fell ill with tuberculosis (TB) in 2010 and 1.4 million died from the disease. Although antibiotics to treat TB were developed in the 1950s and are effective against a …
EPUB
Engels
DRM
€54.05
Board on Health Sciences Policy & Institute of Medicine: Envisioning a Transformed Clinical Trials Enterprise in the United States
There is growing recognition that the United States’ clinical trials enterprise (CTE) faces great challenges. There is a gap between what is desired – where medical care is provided solely based on h …
PDF
Engels
DRM
€3.85
Board on Health Sciences Policy & Institute of Medicine: Envisioning a Transformed Clinical Trials Enterprise in the United States
There is growing recognition that the United States’ clinical trials enterprise (CTE) faces great challenges. There is a gap between what is desired – where medical care is provided solely based on h …
EPUB
Engels
DRM
€51.47
Board on Health Sciences Policy & Institute of Medicine: Developing and Strengthening the Global Supply Chain for Second-Line Drugs for Multidrug-Resistant Tuberculosis
To effectively treat patients diagnosed with drug-resistant (DR) tuberculosis (TB) and protect the population from further transmission of this infectious disease, an uninterrupted supply of quality- …
PDF
Engels
DRM
€3.83
Board on Health Sciences Policy & Institute of Medicine: Developing and Strengthening the Global Supply Chain for Second-Line Drugs for Multidrug-Resistant Tuberculosis
To effectively treat patients diagnosed with drug-resistant (DR) tuberculosis (TB) and protect the population from further transmission of this infectious disease, an uninterrupted supply of quality- …
EPUB
Engels
DRM
€46.32
Board on Health Sciences Policy & Institute of Medicine: Global Crisis of Drug-Resistant Tuberculosis and Leadership of China and the BRICS
Multidrug-resistant tuberculosis (TB) is caused by bacteria resistant to isoniazid and rifampicin, the two most effective first-line anti-TB drugs, originally developed and introduced in the 1950 and …
PDF
Engels
DRM
€3.79
Board on Health Sciences Policy & Institute of Medicine: Global Crisis of Drug-Resistant Tuberculosis and Leadership of China and the BRICS
Multidrug-resistant tuberculosis (TB) is caused by bacteria resistant to isoniazid and rifampicin, the two most effective first-line anti-TB drugs, originally developed and introduced in the 1950 and …
EPUB
Engels
DRM
€49.92
Board on Health Sciences Policy & Institute of Medicine: Large Simple Trials and Knowledge Generation in a Learning Health System
Randomized clinical trials (RCTs) are often referred to as the "gold standard" of clinical research. However, in its current state, the U.S. clinical trials enterprise faces substantial cha …
PDF
Engels
DRM
€3.81
Board on Health Sciences Policy & Institute of Medicine: Large Simple Trials and Knowledge Generation in a Learning Health System
Randomized clinical trials (RCTs) are often referred to as the "gold standard" of clinical research. However, in its current state, the U.S. clinical trials enterprise faces substantial cha …
EPUB
Engels
DRM
€39.65
Board on Health Sciences Policy & Institute of Medicine: Characterizing and Communicating Uncertainty in the Assessment of Benefits and Risks of Pharmaceutical Products
Despite the extensive body of evidence that informs regulatory decisions on pharmaceutical products, significant uncertainties persist, including the underlying variability in human biology, factors …
PDF
Engels
DRM
€3.80
Board on Health Sciences Policy & Institute of Medicine: Characterizing and Communicating Uncertainty in the Assessment of Benefits and Risks of Pharmaceutical Products
Despite the extensive body of evidence that informs regulatory decisions on pharmaceutical products, significant uncertainties persist, including the underlying variability in human biology, factors …
EPUB
Engels
DRM
€48.77
Board on Health Sciences Policy & Health and Medicine Division: Physician-Assisted Death
The question of whether and under what circumstances terminally ill patients should be able to access life-ending medications with the aid of a physician is receiving increasing attention as a matter …
PDF
Engels
DRM
€3.84
Board on Health Sciences Policy & Health and Medicine Division: Physician-Assisted Death
The question of whether and under what circumstances terminally ill patients should be able to access life-ending medications with the aid of a physician is receiving increasing attention as a matter …
EPUB
Engels
DRM
€57.59
Cost-Effective, and Transparent System of Donor Organ Procurement, Allocation, and Distribution Committee on A Fairer and More Equitable: Realizing the Promise of Equity in the Organ Transplantation System
Each year, the individuals and organizations in the U.S. organ donation, procurement, allocation, and distribution system work together to provide transplants to many thousands of people, but thousan …
EPUB
Engels
DRM
€63.04
